Fortis Escorts, New Delhi, introduced the ARTIS pheno.vision, an advanced AI-powered, robot-assisted hybrid catheterisation laboratory (Cath Lab) designed to support complex cardiac, vascular and image-guided procedures. The new facility combines robotic angiography, AI-powered imaging and hybrid operating room capabilities to enhance procedural precision and flexibility.
The technological advancement strengthens the hospital’s capabilities in treating complex cardiovascular conditions while expanding access to advanced, minimally invasive treatment options. Furthermore, the integrated setup enables clinical teams to coordinate catheter-based interventions and surgical procedures within a single environment when clinically required.
AI-Powered Imaging and Robotic Technology Enhance Procedural Precision
The hybrid Cath Lab integrates artificial intelligence (AI), robotic assistance and advanced three-dimensional visualisation to support procedural planning, image acquisition and device navigation during complex cardiovascular and endovascular interventions. For appropriately selected patients, these capabilities can facilitate minimally invasive, image-guided treatments. Compared with conventional open surgery, certain minimally invasive procedures may reduce surgical trauma, shorten hospital stays and support faster recovery. However, outcomes and complication risks depend on the specific procedure, the patient’s clinical condition and the complexity of the intervention.
Integrated Care for Complex Cardiac and Vascular Conditions
The hybrid Cath Lab is particularly relevant for patients with complex cardiovascular conditions, including older adults, individuals with multiple comorbidities and those with challenging anatomical characteristics. In such cases, the availability of interventional cardiology and surgical capabilities within the same environment can help multidisciplinary teams coordinate treatment more effectively. Moreover, the integrated setup allows clinicians to transition between catheter-based interventions and surgery when necessary, based on the patient’s clinical needs.
Supporting Advanced Cardiac and Vascular Procedures
The ARTIS pheno.vision hybrid Cath Lab supports a broad range of complex cardiovascular and endovascular interventions, including:
Aortic procedures: Endovascular aneurysm repair (EVAR) and complex aortic repairs and replacements.
Structural heart interventions: Transcatheter aortic valve implantation or replacement (TAVI/TAVR), mitral valve interventions, including MitraClip and transcatheter mitral valve replacement (TMVR).
Peripheral vascular interventions: Image-guided procedures for peripheral vascular disease.
Combined cardiac procedures: Selected procedures combining robotic cardiac surgery and angioplasty.
Advanced cardiac device implantation: Procedures involving cardiac resynchronisation therapy defibrillators (CRT-Ds) and leadless pacemakers.
By supporting these interventions within an integrated clinical environment, the technology provides greater procedural flexibility for managing complex cardiac and vascular cases.
Fortis Healthcare Emphasises Access to Advanced Cardiac Treatment
Dr. Ashutosh Raghuvanshi, MD and CEO, Fortis Healthcare, said, “Our aim at Fortis Healthcare is to bring the most advanced technology and clinical expertise together so that patients in India can access world-class cardiac care close to home. The introduction of this robotic hybrid cath lab marks a monumental leap in clinical capabilities by bringing advanced AI-Powered, Robot-Assisted Hybrid Cath Lab precision to complex heart procedures, expanding patient access to cutting-edge minimally invasive therapies. It strengthens our ability to treat the most complex heart and vascular conditions with greater precision and safety.”
Advanced Imaging and Robotic Assistance Support High-Risk Procedures
Dr. Ashok Seth, Chairman, Cardiac Sciences, Fortis Healthcare, highlighted the benefits of combining interventional and surgical capabilities in a single operating environment. He said, “For high-risk patients, the ability to move from a catheter-based procedure to surgery in the same operating room, is a major advantage. Robotic positioning, sharper AI- powered imaging, and a lower radiation dose will help us place devices more accurately in procedures such as TAVI and complex vascular interventions, and make these treatments safer for patients, which were once considered too complex. Fortis Escorts, New Delhi is the only corporate hospital to have integrated this technology.”
Next-Generation Technology Strengthens Cardiovascular Care
Dr. Vikram Aggarwal, Regional Director – Operations, Fortis Healthcare, said, “At Fortis Escorts, New Delhi, our endeavour has always been to ensure that patients have timely access to advanced cardiovascular care, particularly when they present with complex and high-risk conditions. With the integration of this next-generation AI-Powered, Robot-Assisted Hybrid Cath Lab, we will be able to plan and perform complex interventions with greater precision, flexibility and clinical confidence, while having the capability to seamlessly integrate surgical intervention when required.”
As per the press release, the introduction of the ARTIS pheno.vision hybrid Cath Lab marks another step in Fortis Escorts, New Delhi’s adoption of advanced cardiovascular technologies. By combining AI-powered imaging, robotic assistance and integrated surgical capabilities, the hospital aims to strengthen its approach to complex cardiac and vascular care and support more personalised, image-guided treatment pathways.